Leptin and adiponectin levels in patients with ankylosing spondylitis. The effect of infliximab treatment.

Abstract:

BACKGROUND:Adipose tissue-derived leptin and adiponectin control hunger, energy expenditure, insulin sensitivity, endothelial function, reproduction and immunity and are thought to play a role in autoimmune diseases. However, their role in ankylosing spondylitis (AS) is not clearly defined. Tumour necrosis factor ΤNF-α is a potential modulator of adipocytokines. The effect of longterm anti-TNF-α treatment on plasma levels of leptin and adiponectin has not been assessed so far. OBJECTIVES:To assess the effect of a 6-month anti-TNF-α treatment on serum leptin and adiponectin levels in AS patients. METHODS:Thirty men with AS were included in the study. Thirty age- and weight-matched men served as controls. Clinical and biochemical parameters were assessed and serum levels of leptin and adiponectin were measured with enzyme immunoassay methods prior to and after the 6-month treatment with infliximab. RESULTS:Mean age and disease duration of AS patients were 40.6±13.7 and 13.4±8.4 years, respectively. At baseline, AS patients exhibited significantly higher adiponectin (15.4±8.3 vs. 8.6±4.2 μg/ml, p<0.05), but no difference in leptin levels (7.2±2.9 vs. 8.9±6.4 ng/ml, p=NS). Adipocytokines did not correlate with any disease parameter. Body weight of the patients did not change significantly over the 6-month period. Serum levels of leptin and adiponectin did not change significantly after the 6-month treatment. CONCLUSIONS:Adiponectin levels were significantly higher in AS patients compared with controls. Infliximab treatment did not change serum levels of leptin and adiponectin suggesting that the anti-TNF-α treatment may not modulate significantly their levels.

journal_name

Clin Exp Rheumatol

authors

Derdemezis CS,Filippatos TD,Voulgari PV,Tselepis AD,Drosos AA,Kiortsis DN

subject

Has Abstract

pub_date

2010-11-01 00:00:00

pages

880-3

issue

6

eissn

0392-856X

issn

1593-098X

pii

864

journal_volume

28

pub_type

杂志文章
  • Side effects and management of side effects of methotrexate in rheumatoid arthritis.

    abstract::Low-dose methotrexate (MTX) remains the first-line treatment option among the disease-modifying antirheumatic drugs in patients with rheumatoid arthritis. However, diverse side effects are the major reason for MTX withdrawal and change of treatment. The following article reviews the published data on general and organ...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,评审

    doi:

    authors: Albrecht K,Müller-Ladner U

    更新日期:2010-09-01 00:00:00

  • Functional evaluation of TNFAIP3 (A20) in rheumatoid arthritis.

    abstract:OBJECTIVES:To determine the protein expression of TNFAIP3 in synovium and to show the capability of 6q23 intergenic SNPs, associated with rheumatoid arthritis (RA) susceptibility, to influence TNFAIP3 gene transcription. METHODS:Immunohistochemistry for TNFAIP3, NF-kB p65 and phosphorylated NF-kB p65 protein expressio...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Elsby LM,Orozco G,Denton J,Worthington J,Ray DW,Donn RP

    更新日期:2010-09-01 00:00:00

  • Influence of methotrexate on radiographic progression in rheumatoid arthritis: a sixty-month prospective study.

    abstract:OBJECTIVE:To evaluate if methotrexate (MTX) can slow disease progression, as determined radiographically, in comparison to other disease modifying drugs in rheumatoid arthritis (RA) patients. MATERIALS AND METHODS:Pairs of hand and wrist radiographs from 30 patients treated with MTX and 30 treated with D-penicillamine...

    journal_title:Clinical and experimental rheumatology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Drosos AA,Tsifetaki N,Tsiakou EK,Timpanidou M,Tsampoulas C,Tatsis CK,Kotoulas K,Moutsopoulos HM

    更新日期:1997-05-01 00:00:00

  • Gold sodium thiomalate suppresses the differentiation and function of human dendritic cells from peripheral blood monocytes.

    abstract:OBJECTIVE:Gold sodium thiomalate (GST) is a drug commonly used for the treatment of rheumatoid arthritis (RA). To clarify the mechanism of therapeutic effects of GST on RA, we investigated if GST affects the differentiation of dendritic cells (DC), which are thought to play a pivotal role in RA pathogenesis. METHODS:W...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Wang ZY,Morinobu A,Kawano S,Saegusa J,Wang B,Kumagai S

    更新日期:2002-09-01 00:00:00

  • Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection.

    abstract::Cytophagic histiocytic panniculitis (CHP) is a rare panniculitis characterized by systemic features, due to histiocytic infiltration along with haemophagocytosis, which may also appear in bone marrow, spleen, lymph nodes, and liver. Haemophagocytic lymphohistiocytosis (HLH) is a group of autoinflammatory disorders, wh...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Merelli M,Quartuccio L,Bassetti M,Pecori D,Gandolfo S,Avellini C,De Vita S

    更新日期:2015-11-01 00:00:00

  • Two NSAIDs, nimesulide and naproxen, can reduce the synthesis of urokinase and IL-6 while increasing PAI-1, in human OA synovial fibroblasts.

    abstract:OBJECTIVES:To evaluate the effect of therapeutic and pharmacologic concentrations of two non-steroidal anti-inflammatory drugs (NSAIDs), nimesulide and naproxen, on the synthesis of urokinase (uPA), plasminogen activator inhibitor (PAI-1) and interleukin-6 (IL-6) in human synovial fibroblasts isolated from osteoarthrit...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Pelletier JP,Mineau F,Fernandes J,Kiansa K,Ranger P,Martel-Pelletier J

    更新日期:1997-07-01 00:00:00

  • Disease-modifying effects of long-term cyclic iloprost therapy in systemic sclerosis. A retrospective analysis and comparison with a control group.

    abstract:OBJECTIVE:To evaluate the role of iloprost, a derivative of prostacyclin, as a possible disease-modifying agent for systemic sclerosis (SSc). METHODS:Fifty-six consecutive SSc patients treated for a median period of 4 years with cyclic infusions of iloprost for severe Raynaud's phenomenon and ischemic ulcers were comp...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Airò P,Rossi M,Scarsi M,Danieli E,Grottolo A,Zambruni A

    更新日期:2007-09-01 00:00:00

  • Subclinical synovitis detected by ultrasound in children affected by coeliac disease: a frequent manifestation improved by a gluten-free diet.

    abstract:OBJECTIVES:Coeliac disease (CD) is a chronic autoimmune disease of the small intestine caused by the ingestion of gluten, in which musculoskeletal manifestations may occur. Aim of this study was to evaluate the prevalence and severity of joint involvement in paediatric patients with CD using musculoskeletal ultrasound ...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Iagnocco A,Ceccarelli F,Mennini M,Rutigliano IM,Perricone C,Nenna R,Petrarca L,Mastrogiorgio G,Valesini G,Bonamico M

    更新日期:2014-01-01 00:00:00

  • Antibodies to neuroblastoma cells in rheumatoid arthritis: a potential marker for neuropathy.

    abstract:OBJECTIVE:To investigate the prevalence of antibodies to neuroblastoma cells in patients with rheumatoid arthritis (RA) complicated by peripheral neuropathy (PN), and to determine whether there is any relationship of these antibodies with the severity of neuropathy. METHODS:The study was carried out on 28 patients wit...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Salih AM,Nixon NB,Dawes PT,Mattey DL

    更新日期:2000-01-01 00:00:00

  • Lupus women with delivery with higher risk of heart failure compared with those without pregnancy but neutral in major adverse cardiovascular events. A population-based matched cohort study.

    abstract:OBJECTIVES:Limited data exist regarding the incidence rate and relative risks of major adverse cardiovascular events in women with lupus who have successfully delivered compared to those who have not been pregnant. METHODS:A retrospective, population-based matched cohort study was performed on women with lupus from 20...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Wu LS,Liu PH,Lin YS,Lin CP,Chang CJ,Chu PH

    更新日期:2014-01-01 00:00:00

  • The Schnitzler syndrome: chronic urticaria in disguise: a single-centre report of 11 cases and a critical reappraisal of the literature.

    abstract:OBJECTIVES:The Schnitzler syndrome is a rare inflammatory disorder, with a chronic urticaria-like rash and an IgM (rarely IgG) monoclonal gammopathy as cardinal features. Interleukin-1 β is regarded as the key mediator and the interleukin-1 receptor antagonist anakinra has been proposed as first-line treatment. This ca...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Vanderschueren S,van der Veen A

    更新日期:2017-01-01 00:00:00

  • Idiopathic osteoporosis in premenopausal women. Clinical characteristics and bone remodelling abnormalities.

    abstract:OBJECTIVE:Osteoporosis is infrequent in young premenopausal women and is often associated with secondary disorders. However, idiopathic osteoporosis may be found in this setting and few data are known on this condition. Therefore, the aim of this study was to analyse the clinical characteristics and bone remodelling ab...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Peris P,Ruiz-Esquide V,Monegal A,Alvarez L,Martínez de Osaba MJ,Martínez-Ferrer A,Reyes R,Guañabens N

    更新日期:2008-11-01 00:00:00

  • Early and late responses in patients with rheumatoid arthritis who were conventional synthetic disease-modifying anti-rheumatic drug inadequate responders and were treated with tocilizumab or switched to rituximab: an open-label phase 3 trial (MIRAI).

    abstract:OBJECTIVES:To evaluate early and late responses in biological-naïve patients with rheumatoid arthritis (RA) initiating tocilizumab and early tocilizumab non-responders who switched to rituximab. METHODS:In this open-label, non-randomised phase 3 study, RA patients with inadequate response to conventional synthetic DMA...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Dörner T,Schulze-Koops H,Burmester GR,Iking-Konert C,Schmalzing M,Engel A,Kästner P,Kellner H,Kurthen R,Krüger K,Rubbert-Roth A,Schwenke H,Peters MA,Tony HP

    更新日期:2019-11-01 00:00:00

  • Rescue treatment with tocilizumab for Takayasu arteritis resistant to TNF-α blockers.

    abstract::Anti-TNF-α therapy has successfully been used to treat Takayasu arteritis (TA) refractory to conventional immunosuppressive treatment. However, some patients fail to respond even to TNF-α blockers. Interleukin-6 (IL-6) is a key player in the pathogenesis of TA. Preliminary data also suggest efficacy of the IL-6 recept...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Salvarani C,Magnani L,Catanoso MG,Pipitone N,Versari A,Dardani L,Pulsatelli L,Meliconi R,Boiardi L

    更新日期:2012-01-01 00:00:00

  • Severe transient osteoporosis of the hip during pregnancy. Successful treatment with intravenous biphosphonates.

    abstract::A young woman with transient osteoporosis of the hip (TOH) during pregnancy, severe pain, physical disability and marked generalized osteoporosis was treated with intravenous biphosphonates with prompt beneficial effects on both clinical symptoms and bone density. The features of this rare and sometimes underdiagnosed...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Schapira D,Braun Moscovici Y,Gutierrez G,Nahir AM

    更新日期:2003-01-01 00:00:00

  • Interleukin-1 immunoreactive nerve fibres in rat joint synovium.

    abstract::The occurrence of interleukin-1 immunoreactive nerves in the synovial membrane of rat knee joints was investigated by immunohistochemistry. Synovial tissue sections from 11 rats consistently showed interleukin-1 positive nerve fibres. The majority of the fibres appeared in blood vessel walls. However, varicose interle...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Bjurholm A,Ahmed M,Svenson SB,Kreicbergs A,Schultzberg M

    更新日期:1994-11-01 00:00:00

  • Rheumatic manifestations of immune deficiency.

    abstract::This article reviews the rheumatic manifestation of the immune deficiency disorders. In particular, the rheumatic manifestations of hypogammaglobulinaemia and the acquired immune deficiency syndrome (AIDS) are discussed. ...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,评审

    doi:

    authors: Preston SJ,Buchanan WW

    更新日期:1989-09-01 00:00:00

  • Wegener s granulomatosis with granulomatous liver involvement.

    abstract::We report on a patient with biopsy proven systemic Wegener's granulomatosis (WG) with a granulomatous necrotising manifestation of WG in the liver, lung, parotid gland and skin with subsequent death of liver failure. Liver involvement in WG is an exceedingly rare, though potentially fatal, organ manifestation of WG. ...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Holl-Ulrich K,Klass M

    更新日期:2010-01-01 00:00:00

  • Homing and efficacy of intra-articular injection of autologous mesenchymal stem cells in experimental chondral defects in dogs.

    abstract:OBJECTIVES:This study was intended to verify the likelihood of homing of intra-articularily injected mesenchymal stem cells (MSCs) and its involvement in the healing process of experimentally induced, acute and chronic, partial chondral defects in dogs. METHODS:Partial thickness chondral defects were created on the la...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Mokbel A,El-Tookhy O,Shamaa AA,Sabry D,Rashed L,Mostafa A

    更新日期:2011-03-01 00:00:00

  • Impact of dosing on treatment with TNF inhibitors: managing dose adjustment.

    abstract::The introduction of tumor necrosis factor (TNF) inhibitors for the treatment of rheumatoid arthritis (RA) represented a significant advance in the treatment of this debilitating disease, and led to dramatic changes in overall treatment goals and guidelines. Despite these advances, best practice use of TNF inhibitors i...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,评审

    doi:

    authors: Combe B

    更新日期:2010-05-01 00:00:00

  • Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands.

    abstract:OBJECTIVES:To determine whether ultrasonographic findings of the synovio-entheseal complex of the hand small joints could be used to differentiate between early rheumatoid and early psoriatic arthritis. METHODS:Thirty-four early rheumatoid and 26 early psoriatic arthritis patients with a prevalent involvement of the h...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Zabotti A,Salvin S,Quartuccio L,De Vita S

    更新日期:2016-05-01 00:00:00

  • Can routine clinical measures predict ultrasound-determined synovitis and remission in rheumatoid arthritis patients?

    abstract:OBJECTIVES:The purpose of this study was to determine if routine clinical measures can predict the presence and severity of ultrasound synovitis in rheumatoid arthritis (RA) patients. METHODS:Bilateral 1-5 MCP (metacarpopharangeal) and wrist joints were examined using power Doppler (PD) ultrasound (US). Correlations b...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Nemoto T,Ogasawara M,Matsuki Y,Murayama G,Yamada Y,Sugisaki N,Ando S,Minowa K,Kon T,Tada K,Matsushita M,Yamaji K,Tamura N,Takasaki Y

    更新日期:2014-01-01 00:00:00

  • Burden of depressive symptoms in South African public healthcare patients with established rheumatoid arthritis: a case-control study.

    abstract:OBJECTIVES:The burden of depressive symptoms and how demographic and disease characteristics relate to depressive symptoms in patients with rheumatoid arthritis (RA) that belong to developing populations, are currently unknown and were therefore assessed in a case-control study in public healthcare patients in South Af...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Solomon A,Christian BF,Woodiwiss AJ,Norton GR,Dessein PH

    更新日期:2011-05-01 00:00:00

  • Low dose etanercept treatment for maintenance of clinical remission in ankylosing spondylitis.

    abstract:OBJECTIVES:To investigate the efficacy and safety of low-dose etanercept treatment after clinical remission of ankylosing spondylitis (AS) in the real world. METHODS:Data on 134 AS patients who were treated with etanercept for more than 12 months and achieved clinical remission (BASDAI<4 and CRP<0.5 mg/dL) were extrac...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Park JW,Yoon YI,Lee JH,Park JK,Lee EB,Song YW,Lee EY

    更新日期:2016-07-01 00:00:00

  • A novel modality of BAFF-specific inhibitor AMG623 peptibody reduces B-cell number and improves outcomes in murine models of autoimmune disease.

    abstract:OBJECTIVES:AMG623, also known as A-623, is an antagonist of B-cell activating factor (BAFF). The present study was to evaluate the effects of AMG623 on murine models of autoimmune diseases. METHODS:AMG623 was generated through phage library. Inhibitory activities of AMG623 against human and murine BAFF were measured b...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Hsu H,Khare SD,Lee F,Miner K,Hu YL,Stolina M,Hawkins N,Chen Q,Ho SY,Min H,Xiong F,Boone T,Zack DJ

    更新日期:2012-03-01 00:00:00

  • COX-2 inhibitors and the kidney.

    abstract::Cyclooxygenase-2 (COX-2) selective inhibitors are now extensively used for their anti-inflammatory and analgesic efficacy. Several large controlled trials provide evidence to support the proposition that they cause fewer major gastro-intestinal side effects and less toxicity than routine nonsteroidal anti-inflammatory...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Appel GB

    更新日期:2001-11-01 00:00:00

  • Catastrophic antiphospholipid syndrome (CAS): a rare manifestation of the antiphospholipid antibody syndrome.

    abstract::During the last decade, antiphospholipid antibodies and their clinical manifestations have given rise to increasing interest and have been associated with a wide spectrum of clinic expression, including arterial and venous thrombosis, thrombocytopenia, recurrent fetal wastage, Coombs positive haemolysis, livedo reticu...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,评审

    doi:

    authors: Mazzucchelli R,Barbadillo C,Youssef H,Bernaldo de Quiros LB,Mulero J,Andreu-Sanchez JL

    更新日期:1993-11-01 00:00:00

  • Adherence to guidelines for the treatment of Behçet's syndrome in New York and Amsterdam.

    abstract:OBJECTIVES:To assess adherence to published guidelines for the treatment of Behçet's syndrome (BS) in two geographic areas. METHODS:We extracted guideline statements from the 2008 EULAR recommendations. Adherence to these statements was evaluated retrospectively in both New York (USA) and Amsterdam (The Netherlands), ...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Kerstens FG,Turkstra F,Atalay S,van Vugt RM,Swearingen CJ,Yazici Y

    更新日期:2017-11-01 00:00:00

  • Alkaptonuria and ochronosis in three siblings. Ascorbic acid treatment monitored by urinary HGA excretion.

    abstract::Patients with alkaptonuria lack homogentisate 1,2-dioxygenase leading to retention of homogentistic acid (HGA) in body fluids and eventually to tissue deposition of oxidation products, giving rise to the clinical picture of ochronosis. Ascorbic acid is a known inhibitor of the enzyme which catalyses the oxidation of h...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Forslind K,Wollheim FA,Akesson B,Rydholm U

    更新日期:1988-07-01 00:00:00

  • Selective suppression of resting B cell function in patients with systemic lupus erythematosus treated with cyclophosphamide.

    abstract::The immunological function of patients with inactive systemic lupus erythematosus (SLE) receiving chronically administered, low-dose cyclophosphamide (CY) together with prednisolone (PSL) was compared with that of inactive patients receiving PSL alone. A striking selective suppression of "genuine" resting, but not "pa...

    journal_title:Clinical and experimental rheumatology

    pub_type: 杂志文章

    doi:

    authors: Takeno M,Suzuki N,Nagafuchi H,Mizushima Y,Sakane T

    更新日期:1993-05-01 00:00:00